Logo
x

Search

Subscribe Now

autoimmune disorders

Amgen Collaborates with Evoq to Develop Novel Therapies for Autoimmune Disorders

Amgen Collaborates with Evoq to Develop Novel Therapies for Autoimmune Disorders

  • January 14, 2021
Bio-Thera Initiates P-I Study of BAT2206 Proposed Biosimilar to Stelara (ustekinumab)

Bio-Thera Initiates P-I Study of BAT2206 Proposed Biosimilar to Stelara (ustekinumab)

  • September 4, 2020
Pfizer's Amsparity (biosimilar- adalimumab) Receives CHMP's Positive Opinion for Inflammatory and Autoimmune Disorders

Pfizer's Amsparity (biosimilar- adalimumab) Receives CHMP's Positive Opinion for Inflammatory and Autoimmune Disorders

  • December 13, 2019
Eli Lilly Signs an Exclusive Worldwide License Agreement with ImmuNext to Develop Therapies for Autoimmune Disorders

Eli Lilly Signs an Exclusive Worldwide License Agreement with ImmuNext to Develop Therapies for Autoimmune Disorders

  • March 27, 2019
Imbrium Signs a License Agreement with TetraGenetics for its TetraExpress Technology

Imbrium Signs a License Agreement with TetraGenetics for its TetraExpress Technology

  • February 27, 2019
Sandoz's Hyrimoz (adalimumab) Receives EU Approval for Autoimmune Disorders

Sandoz's Hyrimoz (adalimumab) Receives EU Approval for Autoimmune Disorders

  • July 27, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.